您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报 (医学版) ›› 2020, Vol. 58 ›› Issue (2): 21-28.doi: 10.6040/j.issn.1671-7554.0.2019.1034

• • 上一篇    下一篇

过表达YAP基因通过PI3K/AKT/mTOR信号通路促进舌鳞癌增殖

王莹,张雅菲,文勇   

  1. 山东大学口腔医学院 口腔医院种植科, 山东省口腔生物材料与组织再生工程实验室, 〓〓〓〓山东省口腔组织再生重点实验室, 山东 济南 250012
  • 出版日期:2020-02-10 发布日期:2022-09-27
  • 通讯作者: 文勇. E-mail:wenyong@sdu.edu.cn
  • 基金资助:
    山东省自然科学基金(ZR2018MH018);山东省医药卫生科技发展计划(2017WS111);山东省博士后创新项目专项资金(201703071)

YAP gene overexpression promotes tongue squamous carcinoma growth through PI3K/AKT/mTOR signaling pathway

WANG Ying, ZHANG Yafei, WEN Yong   

  1. Department of Implantology, School and Hospital of Stomatology, Shandong University &
    Shandong Key Laboratory of Oral Tissue regeneration &
    Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, Jinan 250012, Shandong, China
  • Online:2020-02-10 Published:2022-09-27

PDF (PC)

17

摘要： 目的 基于PI3K/AKT/mTOR信号通路,探究过表达YAP基因对舌鳞癌细胞增殖和凋亡的分子学调控机制。 方法 构建稳定过表达YAP基因的舌鳞癌CAL27和SCC25细胞系。采用CCK-8和流式细胞术分析过表达YAP基因对细胞增殖、周期和凋亡的影响。蛋白免疫印迹法分析过表达YAP基因对细胞内CDK4、CDK6、p21、BAX及对PI3K/AKT/mTOR信号通路的影响。 结果 CAL27细胞和SCC25细胞中过表达YAP组YAP mRNA较对照组升高(t=-19.29, P<0.001; t=-5.44, P<0.001),且过表达YAP组的YAP蛋白表达量较对照组增加(t=-31.28, P<0.001; t=-42.84, P<0.001);过表达YAP组的G1期细胞比例减少,过表达YAP组S期细胞比例较对照组升高;过表达YAP组的早期凋亡和晚期凋亡细胞都减少;过表达YAP组细胞中CDK4、CDK6、BCL-2、PARP等蛋白表达升高,p21、BAX及caspase3蛋白的表达减少;过表达YAP基因可使CAL27和SCC25细胞内AKT(tCAL27=-30.60, P<0.001; tSCC25=-16.77, P<0.001)、p-AKT(tCAL27=-10.23, P<0.001; tSCC25=-10.67, P<0.001),mTOR(tCAL27=-13.93, P<0.001; tSCC25=-9.57, P<0.001)、p-mTOR(tCAL27=-17.17, P<0.001; tSCC25=-8.51, P<0.001)表达量较对照组增高。 结论 过表达YAP基因可以通过PI3K/AKT/mTOR信号通路促进CAL27和SCC25细胞增殖并抑制细胞凋亡。

关键词: 过表达YAP基因, 舌鳞癌, 增殖, 凋亡, PI3K/AKT/mTOR信号通路

Abstract: Objective To explore the molecular mechanism of YAP gene overexpression on the proliferation and apoptosis of tongue squamous carcinoma cells through the PI3K/AKT/mTOR signaling pathway. Methods CAL27 and SCC25 cell lines overexpressing YAP gene were constructed. The effects of YAP gene overexpression on cell proliferation, cell cycle and apoptosis were detected with CCK-8 and flow cytometry. Effects of YAP gene overexpression on the CDK4, CDK6, p21, BAX and PI3K/AKT/mTOR signaling pathways were analyzed with Western blotting. Results The mRNA expression of YAP in the overexpressing group was higher than that in the control group(t=-19.29, P<0.001; t=-5.44, P<0.001), and the protein expression was also higher(t=-31.28, P<0.001; t=-42.84, P<0.001). In the overexpressing group, the proportion of cells in G1 phase decreased, while the proportion of cells in S phase 山 东 大 学 学 报 (医 学 版)58卷2期 -王莹,等.过表达YAP基因通过PI3K/AKT/mTOR信号通路促进舌鳞癌增殖 \=-increased; the numbers of both early apoptosis and late apoptosis cells reduced; the protein expressions of CDK4, CDK6, BCL-2, PARP increased, while the protein expressions of p21, BAX and caspase3 decreased. YAP gene overexpression increased the expressions of AKT(tCAL27=-30.60, P<0.001; tSCC25=-16.77, P<0.001), p-AKT(tCAL27=-10.23, P<0.001; tSCC25=-10.67, P<0.001), mTOR(tCAL27=-13.93, P<0.001; tSCC25=-9.57, P<0.001), and p-mTOR(tCAL27=-17.17, P<0.001; tSCC25=-8.51, P<0.001). Conclusion YAP gene overexpression promotes proliferation of CAL27 and SCC25 cells and inhibits apoptosis through the PI3K/AKT/mTOR signaling pathway.

Key words: YAP gene overexpression, Tongue squamous cell carcinoma, Proliferation, Apoptosis, PI3K/AKT/mTOR signaling pathway

中图分类号: 

  • R739.86
[1] 陈新, 徐文华, 周健, 等. 口腔鳞状细胞癌现状[J]. 口腔医学, 2017, 37(5): 462-465. CHEN Xin, XU Wenhua, ZHOU Jian, et al. Current situation of oral squamous cell carcinoma[J]. Stomatology, 2017, 37(5): 462-465.
[2] Oliver JR, Wu SP, Chang CM, et al. Survival of oral tongue squamous cell carcinoma in young adults[J]. Head Neck, 2019, 41(9): 2960-2968.
[3] Ding J, Yang C, Yang S. LINC00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC2[J]. J Oral Pathol Med, 2018, 47(5): 468-476.
[4] Sasahira T, Kirita T. Hallmarks of cancer-related newly prognostic factors of oral squamous cell carcinoma[J]. Int J Mol Sci, 2018, 19(8): 2413
[5] Wang Y, Xu X, Maglic D, et al. Comprehensive molecular characterization of the hippo signaling pathway in cancer[J]. Cell Rep, 2018, 25(5): 1304-1317.
[6] Hiemer SE, Zhang L, Kartha VK, et al. A YAP/TAZ-regulated molecular signature is associated with oral squamous cell carcinoma[J]. Mol Cancer Res, 2015, 13(6): 957-968.
[7] 石丹, 范德生, 甄蕾, 等. PI3K/Akt信号通路抑制剂在舌鳞癌细胞系增殖和凋亡中的作用[J]. 口腔颌面外科杂志, 2010, 20(5): 324-326. SHI Dan, FAN Desheng, ZHEN Lei, et al. PI3K/Akt pathway inhibitor on the apoptosis of human tongue squamous carcinoma cell tca8113[J]. Journal of Oral and Maxillofacial Surgery, 2010, 20(5): 324-326.
[8] Yang H, Wen L, Wen M, et al. FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop[J]. Anticancer Drugs, 2018, 29(3): 216-226.
[9] Ion Ciuca Marasescu FI, Marasescu PC, Matei M, et al. Epidemiological and histopathological aspects of tongue squamous cell carcinomas-retrospective study[J]. Curr Health Sci J, 2018, 44(3): 211-224.
[10] Karatas OF, Oner M, Abay A, et al. MicroRNAs in human tongue squamous cell carcinoma: from pathogenesis to therapeutic implications[J]. Oral Oncol, 2017, 67(1):124-130.
[11] Jain S, Pathak K, Vaidya A. Molecular therapy using siRNA: recent trends and advances of multi target inhibition of cancer growth[J]. Int J Biol Macromol, 2018, 116(1): 880-892.
[12] Le Tourneau C, Faivre S, Siu LL. Molecular targeted therapy of head and neck cancer: review and clinical development challenges[J]. Eur J Cancer, 2007, 43(17): 2457-2466.
[13] Yagi R, Chen LF, Shigesada K, et al. A WW domain-containing yes-associated protein(YAP)is a novel transcriptional co-activator[J]. EMBO J, 1999, 18(9): 2551-2562.
[14] Xie Q, Chen J, Feng H, et al. YAP/TEAD-mediated transcription controls cellular senescence[J]. Cancer Res, 2013, 73(12): 3615-3624.
[15] Zaidi SK, Sullivan AJ, Medina R, et al. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription[J]. EMBO J, 2004, 23(4): 790-799.
[16] Moroishi T, Hansen CG, Guan KL. The emerging roles of YAP and TAZ in cancer[J]. Nat Rev Cancer, 2015, 15(2): 73-79.
[17] Noto A, De Vitis C, Pisanu ME, et al. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ[J]. Oncogene, 2017, 36(32): 4671-4672.
[18] Sorrentino G, Ruggeri N, Zannini A, et al. Glucocorticoid receptor signalling activates YAP in breast cancer[J]. Nat Commun, 2017, 8(1): 14073.
[19] Muramatsu T, Imoto I, Matsui T, et al. YAP is a candidate oncogene for esophageal squamous cell carcinoma[J]. Carcinogenesis, 2011, 32(3): 389-398.
[20] Croci O, De Fazio S, Biagioni F, et al. Transcriptional integration of mitogenic and mechanical signals by Myc and YAP[J]. Genes Dev, 2017, 31(20): 2017-2022.
[21] Gulappa T, Reddy RS, Suman S, et al. Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cells[J]. Cancer Lett, 2013, 337(2): 177-183.
[22] Guan Z, Tan J, Gao W, et al. Circular RNA hsa_circ_0016788 regulates hepatocellular carcinoma tumorigenesis through miR-486/CDK4 pathway[J]. J Cell Physiol, 2018, 234(1): 500-508.
[23] Lulla AR, Slifker MJ, Zhou Y, et al. miR-6883 family miRNAs target CDK4/6 to induce G1 phase cell-cycle arrest in colon cancer cells[J]. Cancer Res, 2017, 77(24): 6902-6913.
[24] Czabotar PE, Lessene G, Strasser A, et al. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy[J]. Nat Rev Mol Cell Biol, 2014, 15(1): 49-63.
[25] Inoue-Yamauchi A, Jeng PS, Kim K, et al. Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy[J]. Nat Commun, 2017, 8(1):16078.
[26] Polivka J Jr, Janku F. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway[J]. Pharmacol Ther, 2014, 142(2): 164-175.
[27] Massarelli E, Liu DD, Lee JJ, et al. Akt activation correlates with adverse outcome in tongue cancer[J]. Cancer, 2005, 104(11): 2430-2436.
[28] Li SH, Chien CY, Huang WT, et al. Prognostic significance and function of mammalian target of rapamycin in tongue squamous cell carcinoma[J]. Sci Rep, 2017, 7(1): 8178.
[29] Zhang H, Liu J, Fu X, et al. Identification of key genes and pathways in tongue squamous cell carcinoma using bioinformatics analysis[J]. Med Sci Monit, 2017, 23(1):5924-5932.
[1] 张士宝 刘庆勇 阮喜云 陈杰 张建军 李宗武 杨广笑 王全颖. NT4-SAC-HA2-TAT融合基因表达载体的构建及鉴定[J]. 山东大学学报(医学版), 2209, 47(6): 15-19.
[2] 王晓磊 张海涛 张辉 郭成浩. 舒血宁注射液对高碘致培养血管内皮细胞损伤的保护作用[J]. 山东大学学报(医学版), 2209, 47(6): 38-.
[3] 鹿向东 杨伟 徐广明 曲元明. 脑膜瘤中PPAR-γ的表达及曲格列酮对脑膜瘤培养细胞生长的影响[J]. 山东大学学报(医学版), 2209, 47(6): 65-.
[4] 赵舸,邹存华,宋冬冬,赵淑萍. 丹参酮IIA对子宫内膜癌细胞增殖与凋亡的影响[J]. 山东大学学报 (医学版), 2022, 60(9): 53-58.
[5] 张振伟,李佳,陈克明. IGF2BP2/m6A/ITGA5信号轴调控肾透明细胞增殖和迁移[J]. 山东大学学报 (医学版), 2022, 60(9): 74-84.
[6] 刘敏,张玉超,马小莉,刘昕宇,孙露,左丹,刘元涛. 孤核受体NR4A1在H2O2诱导小鼠肾脏足细胞损伤中的作用[J]. 山东大学学报 (医学版), 2022, 60(5): 16-21.
[7] 申晓畅,孙一卿,颜磊,赵兴波. 芳基烃受体核转位因子样蛋白2在子宫内膜癌中的表达[J]. 山东大学学报 (医学版), 2022, 60(5): 74-80.
[8] 宋甜,付琳琳,王秋敏,杨晓,王莹,边月红,石玉华. 脂肪酸转运蛋白1在多囊卵巢综合征患者颗粒细胞中的表达[J]. 山东大学学报 (医学版), 2022, 60(2): 22-26.
[9] 亓梦雨,周敏然,孙洺山,李世洁,陈春燕. T大颗粒淋巴细胞白血病合并原发性骨髓纤维化1例[J]. 山东大学学报 (医学版), 2022, 60(2): 118-120.
[10] 李卉,姜朝阳,刘岩,张曼. 组蛋白去乙酰化酶SIRT1调控氧化低密度脂蛋白诱导巨噬细胞凋亡的表达[J]. 山东大学学报 (医学版), 2022, 60(1): 6-12.
[11] 王芳,陈华,商丽红,李茹月,李咏梅,杨玉娥,哈春芳. U0126对子宫内膜异位症大鼠MEK/ERK/NF-κB通路及增殖侵袭的影响[J]. 山东大学学报 (医学版), 2021, 59(9): 148-154.
[12] 张倩,秦明明,何学佳,蔡秋景,张亚民,李庆苏,朱薇薇. 骨化三醇对哮喘中TGF-β1所诱导上皮间充质转化的调控作用[J]. 山东大学学报 (医学版), 2021, 59(7): 10-18.
[13] 卢游,且迪,伍晋辉,杨凡. 干预Sonic Hedgehog信号通路对宫内发育迟缓新生大鼠学习记忆能力的影响[J]. 山东大学学报 (医学版), 2021, 59(5): 82-89.
[14] 南莉,杨凯转,张一帆. 室内照明白色发光二极管对大鼠视网膜的影响[J]. 山东大学学报 (医学版), 2021, 59(4): 56-62.
[15] 刘淑丹,张飞燕,郭松林,梁雪云,陈冬梅. 氧化苦参碱改善缺氧缺血引起的HaCaT细胞氧化应激损伤[J]. 山东大学学报 (医学版), 2021, 59(3): 26-34.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发